CIK 0001157601 · Large accelerated filer
MADRIGAL PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- MDGL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (267) 824-2827
- Business address
- 1001 CONSHOHOCKEN STATE ROAD, SUITE 2-350, WEST CONSHOHOCKEN, PA
- Former names
- MADRIGAL PHARMACEUTICALS, INC., SYNTA PHARMACEUTICALS CORP
- Open-market buys, last 90 days
- $35,023,032
- in 1 filing
- Open-market sales, last 90 days
- $7,011,938
- in 3 filings, $6.7M under 10b5-1 plans
Net +$28,011,094. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-03-06 | Dier Mardi EVP and CFO | Sale 10b5-1 | −116 | $432.56 | $50K | 12,850 |
| 2026-03-06 | Dier Mardi EVP and CFO | Sale 10b5-1 | −160 | $434.20 | $69K | 12,690 |
| 2026-03-06 | Dier Mardi EVP and CFO | Sale 10b5-1 | −80 | $435.32 | $35K | 12,610 |
| 2026-03-06 | Dier Mardi EVP and CFO | Sale 10b5-1 | −80 | $436.69 | $35K | 12,530 |
| 2026-03-06 | Dier Mardi EVP and CFO | Sale 10b5-1 | −40 | $437.65 | $18K | 12,490 |
| 2026-03-06 | Sibold William John President and CEO | Sale | −1,663 | $431.94 | $718K | 161,829 |
| 2026-03-06 | Kelley Shannon T General Counsel | Sale | −360 | $431.94 | $155K | 12,138 |
| 2026-03-06 | Huntsman Carole Chief Commercial Officer | Sale | −419 | $431.94 | $181K | 12,692 |
| 2026-03-06 | Taub Rebecca Director | Sale | −491 | $431.94 | $212K | 452,213 |
| 2026-03-04 | Dier Mardi EVP and CFO | Grant or award 10b5-1 | +5,215 | 14,472 | ||
| 2026-03-04 | Dier Mardi EVP and CFO | Grant or award · Stock Option (Right to Buy) 10b5-1 | +6,519 | 6,519 | ||
| 2026-03-04 | Sibold William John President and CEO | Grant or award | +14,995 | 163,492 | ||
| 2026-03-04 | Sibold William John President and CEO | Grant or award · Stock Option (Right to Buy) | +18,743 | 18,743 | ||
| 2026-03-04 | Kelley Shannon T General Counsel | Grant or award | +4,017 | 12,498 | ||
| 2026-03-04 | Kelley Shannon T General Counsel | Grant or award · Stock Option (Right to Buy) | +5,022 | 5,022 | ||
| 2026-03-04 | Huntsman Carole Chief Commercial Officer | Grant or award | +3,989 | 13,111 | ||
| 2026-03-04 | Huntsman Carole Chief Commercial Officer | Grant or award · Stock Option (Right to Buy) | +4,986 | 4,986 | ||
| 2026-03-04 | Soergel David Chief Medical Officer | Grant or award | +4,374 | 11,919 | ||
| 2026-03-04 | Soergel David Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +5,467 | 5,467 | ||
| 2026-03-02 | Dier Mardi EVP and CFO | Sale | −1,183 | $427.21 | $505K | 9,257 |
Page 5 of 82 · 1,629 trades